MINNEAPOLIS, Feb. 11 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC
Bulletin Board: BTEL.OB) announced strong sales and earnings for its second
quarter ended December 31, 2007. The Company had net earnings of $206,000,
or $0.07 per diluted share, on revenues of $2,859,000. This compares to net
earnings of $120,000, or $0.04 per diluted share, on revenues of $2,705,000
for the second quarter of last year. For the six months ended December 31,
2007, Biotel had net earnings of $376,000, or $0.13 per diluted share, on
revenues of $5,610,000. This compares to net earnings of $109,000, or $0.04
per share, on revenues of $5,129,000 for the firsts six months last year.
Highlights for the second quarter are as follows:
-- 5.7% revenue growth, year over year
-- Gross margin of 44.7%, up from 40.2% a year ago
-- Operating margin of 11.1% versus 7.2% a year ago
-- Net margin of 7.2% versus 4.4% a year ago
-- Strong balance sheet with no long-term debt
-- Stockholders' equity of $4,333,000, up 25.2% year over year
"We are pleased with our business progress in the second quarter,
achieving strong improvement in margins as well as year over year growth in
product and service revenues," Biotel President and CEO Steve Springrose
said. "Underlying these results were strong sales of our Braemar cardiac
event recorders, Holter devices, liposuction and other medical devices. On
top of this, revenues from our Agility 24/7 cardiac monitoring services
continued to grow, and the service component of our business contributed
significantly to gross margin improvement. Year-over year growth in R&D
continued to support our new product pipeline, including the ER900 Wireless
Event Recorder, as well as other new cardiac event and Holter recorders. In
keeping with our long-term strategy, Biotel continues to serve as a
development partner to medical corporations seeking new devices and
clinical research services."
'/>"/>
| SOURCE Biotel Inc. Copyright©2008 PR Newswire. All rights reserved |